The estimated Net Worth of Alistair Macdonald is at least $27.2 Миллион dollars as of 2 August 2021. Mr. Macdonald owns over 40,263 units of Syneos Health Inc stock worth over $8,413,765 and over the last 8 years he sold SYNH stock worth over $11,145,506. In addition, he makes $7,646,360 as Chief Executive Officer и Director at Syneos Health Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Macdonald SYNH stock SEC Form 4 insiders trading
Alistair has made over 22 trades of the Syneos Health Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 40,263 units of SYNH stock worth $3,550,794 on 2 August 2021.
The largest trade he's ever made was selling 64,497 units of Syneos Health Inc stock on 1 February 2021 worth over $4,883,068. On average, Alistair trades about 7,912 units every 38 days since 2016. As of 2 August 2021 he still owns at least 195,760 units of Syneos Health Inc stock.
You can see the complete history of Mr. Macdonald stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Alistair Macdonald biography
Alistair Macdonald serves as Chief Executive Officer, Director of the Company. He has been our Chief Executive Officer ("CEO") and a member of our Company's Board of Directors (the "Board") since October 2016. He joined our Company in May 2002 and has served in various senior leadership roles during that time. Prior to his current role, Mr. Macdonald most recently served as President and Chief Operating Officer from January 2015 to September 2016 and Chief Operating Officer from January 2013 to January 2015. He also served as our President, Clinical Development Services from March 2012 to January 2013, Executive Vice President of our Global Oncology Unit from February 2011 to March 2012, Executive Vice President, Strategic Development from October 2009 to February 2011, and Senior Vice President, Biometrics from May 2002 to September 2009. He currently serves as Chairman of the Board for the Association of Clinical Research Organizations (ACRO). He received his Master of Science in Environmental Diagnostics from Cranfield University.
What is the salary of Alistair Macdonald?
As the Chief Executive Officer и Director of Syneos Health Inc, the total compensation of Alistair Macdonald at Syneos Health Inc is $7,646,360. There are no executives at Syneos Health Inc getting paid more.
How old is Alistair Macdonald?
Alistair Macdonald is 50, he's been the Chief Executive Officer и Director of Syneos Health Inc since 2016. There are 11 older and 7 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
What's Alistair Macdonald's mailing address?
Alistair's mailing address filed with the SEC is C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE, NC, 27560.
Insiders trading at Syneos Health Inc
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado и Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
What does Syneos Health Inc do?
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
What does Syneos Health Inc's logo look like?
Complete history of Mr. Macdonald stock trades at Syneos Health Inc
Syneos Health Inc executives and stock owners
Syneos Health Inc executives and other stock owners filed with the SEC include:
-
Alistair Macdonald,
Chief Executive Officer, Director -
Jason Meggs,
Chief Financial Officer -
Paul Colvin,
President - Clinical Solutions -
Michelle Keefe,
President - Commercial Solutions -
Jonathan Olefson,
General Counsel, Corporate Secretary -
Alistair Macdonald,
CEO & Director -
Jason M. Meggs,
Chief Financial Officer -
Paul D. Colvin,
Chief Bus. Officer -
Michelle Keefe,
Pres of Commercial Solutions -
Jonathan Olefson,
Gen. Counsel & Corp. Sec. -
John Dineen,
Independent Chairman of the Board -
William Klitgaard,
Independent Director -
Kenneth Meyers,
Independent Director -
Linda Harty,
Independent Director -
Matthew Monaghan,
Independent Director -
Joshua Nelson,
Independent Director -
Todd Abbrecht,
Independent Director -
Bernadette Connaughton,
Independent Director -
Thomas Allen,
Independent Director -
John Maldonado,
Independent Director -
Ronnie Speight,
Senior Vice President, Investor Relations -
Robert Parks,
Executive Vice President, Chief Accounting Officer -
Lisa van Capelle,
Chief Human Resource Officer -
Dr. Judith Ng-Cashin M.D.,
Chief Scientific Officer -
Kristen Spensieri,
Global Head of Corp. Communications & Marketing -
Larry A. Pickett Jr.,
Chief Information & Digital Officer -
Dr. Judith Ng-Cashin,
Chief Scientific Officer -
Donna Hildebrand Kralowetz,
Sr. VP of Fin. & Principal Accounting Officer -
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Ma Doubl...,
-
Tom Allen,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Christopher L Gaenzle,
CAO, GC & Sec -
Michael Adam Bell,
Director -
Joshua M Nelson,
-
Todd M Abbrecht,
-
H. Lee Advisors, Llcthl Hol...,
-
H. Lee Advisors, Llc Thomas...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llc Thomas...,
-
H. Lee Advisors, Llcthl Fun...,
-
H. Lee Equity Fund Vi, L.P....,
-
Christian Tucat,
Chief Business Officer -
Michael Lee Brooks,
Chief Operating Officer -
Barbara W. Bodem,
Director -
Alfonso G Zulueta,
Director -
Stanford Rudnick,
See remarks -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Michael J. Bonello,
Chief Financial Officer -
Donna Hildebrand Kralowetz,
EVP, Chief Accounting Officer -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Maap Gpe...,
-
David S. Wilkes,
Director